|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Prepaid | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Accounts receivable, net allowance of $1,801,299 and $1,568,030 respectively | ||||||||||||||||||||
| Other receivables | ||||||||||||||||||||
| Due from related parties, current portion | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Right of use assets - operating | ||||||||||||||||||||
| Right of use assets - financing | ||||||||||||||||||||
| Investment - related party | ||||||||||||||||||||
| Maintenance reserves | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholder's Equity (Deficit) | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued compensation | ||||||||||||||||||||
| Loans payable | ||||||||||||||||||||
| Interest payable | ||||||||||||||||||||
| Convertible notes payable, net of debt discount of $0 and $5,210, respectively | ||||||||||||||||||||
| Derivative liability | ||||||||||||||||||||
| Due to a related party | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Due to related parties | ||||||||||||||||||||
| Right of use liabilities - operating | ||||||||||||||||||||
| Right of use liabilities - financing | ||||||||||||||||||||
| Long-term debt, current portion | ||||||||||||||||||||
| Long-term debt, related parties, current portion | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Right of use liabilities - operating, net of current portion | ||||||||||||||||||||
| Right of use liabilities - financing, net of current portion | ||||||||||||||||||||
| Long-term debt, net of current portion | ||||||||||||||||||||
| Long-term debt, related parties, net of current portion | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' Equity | ||||||||||||||||||||
| Series A Preferred stock: par value $0.001; 155,000 shares authorized; 145,410 issued and outstanding at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Common stock: par value $0.001; 5,000,000,000 shares authorized; 280,848,293 and 280,848,293 issued and outstanding, respectively | ||||||||||||||||||||
| Common stock to be issued | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Stockholders' equity | ||||||||||||||||||||
| Total liabilities and total stockholders' equity | ||||||||||||||||||||
Loading...
